Since November 2021, the SARS-CoV-2 Omicron has spread expeditiously all over the world and gradually superseded the previous attention-capturing the SARS-CoV-2 variants of concern (VOCs). The Omicron variant harbors more ...
Apr 22, 2022
0
12
A new study shows that it is possible to use the genetic sequences of a person's antibodies to predict what pathogens those antibodies will target. Reported in the journal Immunity, the new approach successfully differentiates ...
Apr 21, 2022
0
5
It seems every few weeks we hear about a new COVID variant, and it's hard to know how concerned we ought to be.
Apr 14, 2022
0
21
A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials to treat ...
Apr 13, 2022
0
155
A clinical study from Spain recently confirmed laboratory experiments made by researchers of Goethe University Frankfurt and University of Kent who showed that the protease inhibitor aprotinin prevented cells to be infected ...
Apr 11, 2022
0
8
A new hybrid COVID-19 variant dubbed XE has sparked fresh concerns recently.
Apr 11, 2022
0
26
A group of bat viruses related to SARS-CoV-2 can also infect human cells but uses a different and unknown entryway.
Apr 8, 2022
0
102
New research hints at a possible explanation as to why people with diabetes, asthma and other conditions that involve chronic inflammation are more susceptible to the coronavirus and tend to experience more serious COVID-19.
Apr 7, 2022
0
34
A new study has found that the Novaplex SARS-CoV-2 Variant I, II, and IV real-time PCR assays (from Seegene Technology) can reliably detect SARS-CoV-2 in patient samples and identify known variants of interest and concern. ...
Mar 31, 2022
0
3
New computational simulations of the behavior of SARS-CoV-1 and SARS-CoV-2 spike proteins prior to fusion with human cell receptors show that SARS-CoV-2, the virus that causes COVID-19, is more stable and slower-changing ...
Mar 30, 2022
0
42
